These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 3084648

  • 1. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K, Tilden AB, Balch CM.
    J Immunol; 1986 May 15; 136(10):3910-5. PubMed ID: 3084648
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B.
    Nat Immun Cell Growth Regul; 1987 May 15; 6(3):129-40. PubMed ID: 3114621
    [Abstract] [Full Text] [Related]

  • 3. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.
    Itoh K, Tilden AB, Kumagai K, Balch CM.
    J Immunol; 1985 Feb 15; 134(2):802-7. PubMed ID: 3917475
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H, Ueno Y, Taga K, Matsuda A, Miyawaki T, Taniguchi N.
    J Immunol; 1985 Oct 15; 135(4):2351-6. PubMed ID: 3928745
    [Abstract] [Full Text] [Related]

  • 7. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
    Itoh K, Shiiba K, Shimizu Y, Suzuki R, Kumagai K.
    J Immunol; 1985 May 15; 134(5):3124-9. PubMed ID: 2984283
    [Abstract] [Full Text] [Related]

  • 8. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL, Benike CJ, Phillips JH, Engleman EG.
    J Immunol; 1985 Feb 15; 134(2):794-801. PubMed ID: 3871216
    [Abstract] [Full Text] [Related]

  • 9. Ultrastructural and functional effects of lipopolysaccharide and interleukin-2 on human NK cells.
    Kang YH, Carl M, Watson LP.
    Scanning Microsc; 1988 Sep 15; 2(3):1567-86. PubMed ID: 3059478
    [Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME, Thiele DL, Lipsky PE.
    J Immunol; 1987 Jun 15; 138(12):4185-91. PubMed ID: 3108384
    [Abstract] [Full Text] [Related]

  • 11. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC, Hsiao MH, Pattengale PK.
    Nat Immun Cell Growth Regul; 1991 Jun 15; 10(2):57-70. PubMed ID: 1881400
    [Abstract] [Full Text] [Related]

  • 12. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S.
    J Clin Lab Immunol; 1993 Jun 15; 40(2):47-60. PubMed ID: 7932628
    [Abstract] [Full Text] [Related]

  • 13. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H, Narumi K, Stewart CC, Arbuck SG, Foon KA, Goldrosen MH.
    Anticancer Res; 1992 Jun 15; 12(6B):1925-33. PubMed ID: 1295440
    [Abstract] [Full Text] [Related]

  • 14. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
    Itoh K, Platsoucas CD, Balch CM.
    Cell Immunol; 1987 Sep 15; 108(2):495-500. PubMed ID: 3113744
    [Abstract] [Full Text] [Related]

  • 15. Prerequisite for the induction of lymphokine-activated killer cells from T lymphocytes.
    Sawada H, Abo T, Sugawara S, Kumagai K.
    J Immunol; 1988 May 15; 140(10):3668-73. PubMed ID: 2896211
    [Abstract] [Full Text] [Related]

  • 16. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 15; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 17. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA, Vujanovic NL, Herberman RB, Hiserodt JC.
    J Immunol; 1988 Apr 15; 140(8):2846-52. PubMed ID: 3258622
    [Abstract] [Full Text] [Related]

  • 18. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ, Yang J, Shu S, Rosenberg SA.
    J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106
    [Abstract] [Full Text] [Related]

  • 19. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 20. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
    Lanier LL, Le AM, Cwirla S, Federspiel N, Phillips JH.
    Fed Proc; 1986 Nov 15; 45(12):2823-8. PubMed ID: 3095151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.